HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Sasano Selected Research

Residual Neoplasm

3/2019Programmed death-1 ligands and tumor infiltrating T lymphocytes in primary and lymph node metastasis of esophageal cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Sasano Research Topics

Disease

35Neoplasms (Cancer)
03/2019 - 01/2000
21Breast Neoplasms (Breast Cancer)
06/2017 - 01/2000
16Carcinoma (Carcinomatosis)
03/2019 - 01/2000
6Adenoma (Adenomas)
01/2016 - 03/2000
6Adenocarcinoma
11/2012 - 03/2000
5Noninfiltrating Intraductal Carcinoma (DCIS)
06/2017 - 03/2000
5Cushing Syndrome
01/2007 - 08/2000
5Ductal Carcinoma
05/2005 - 01/2000
5Endometriosis
06/2001 - 01/2000
4Esophageal Squamous Cell Carcinoma
03/2019 - 09/2000
4Hyperaldosteronism (Conn Syndrome)
01/2016 - 02/2000
4Ovarian Epithelial Carcinoma
01/2005 - 12/2000
4Endometrial Neoplasms (Endometrial Cancer)
07/2001 - 01/2000
3Hypertension (High Blood Pressure)
01/2016 - 04/2001
3Prostatic Neoplasms (Prostate Cancer)
01/2013 - 01/2009
3Adrenocortical Adenoma (Disease, Conn's)
01/2007 - 08/2000
3Hyperplasia
02/2005 - 09/2000
3Ovarian Neoplasms (Ovarian Cancer)
01/2005 - 09/2001
3Cysts
01/2005 - 06/2000
3Endometrial Hyperplasia
07/2001 - 01/2000
3Adrenocortical Carcinoma
08/2000 - 02/2000
2Inflammation (Inflammations)
04/2014 - 06/2001
2Thrombosis (Thrombus)
04/2014 - 10/2000
2Atrophy
09/2013 - 01/2007
2Atherosclerosis
08/2006 - 12/2001
2Biliary Atresia
12/2001 - 07/2001
2Endometrioid Carcinoma
07/2001 - 10/2000
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2001 - 01/2000
2Ganglioneuroblastoma
01/2001 - 04/2000
2Pheochromocytoma
01/2001 - 04/2000
2Neuroblastoma
01/2001 - 04/2000
2Carcinogenesis
01/2001 - 03/2000
1Esophageal Neoplasms (Esophageal Cancer)
03/2019
1Residual Neoplasm
03/2019
1Lymphatic Metastasis
03/2019
1Fibrosis (Cirrhosis)
04/2014

Drug/Important Bio-Agent (IBA)

14Messenger RNA (mRNA)IBA
01/2012 - 02/2000
13Estrogens (Estrogen)FDA Link
06/2017 - 01/2000
13Biological ProductsIBA
01/2013 - 03/2000
9Aromatase (CYP19)IBA
06/2017 - 01/2000
9EnzymesIBA
01/2007 - 01/2000
9SteroidsIBA
06/2001 - 01/2000
8Estrogen ReceptorsIBA
06/2017 - 01/2000
8Estrogen Receptor alphaIBA
07/2013 - 03/2000
8AndrogensIBA
01/2013 - 05/2000
7AldosteroneIBA
01/2016 - 02/2000
6Hydrocortisone (Cortisol)FDA LinkGeneric
09/2013 - 02/2001
6Progesterone Receptors (Progesterone Receptor)IBA
07/2013 - 12/2000
5Estradiol (Delestrogen)FDA LinkGeneric
06/2017 - 01/2000
5Aromatase InhibitorsIBA
07/2013 - 01/2000
5Hormones (Hormone)IBA
05/2001 - 02/2000
4Dehydroepiandrosterone (DHEA)IBA
01/2013 - 12/2000
43 (or 17)-beta-hydroxysteroid dehydrogenaseIBA
01/2009 - 02/2000
4IsoenzymesIBA
09/2001 - 03/2000
3ReninIBA
01/2016 - 04/2000
3Trastuzumab (Herceptin)FDA Link
05/2014 - 01/2001
3dehydroepiandrosterone sulfotransferaseIBA
09/2013 - 04/2001
3Testosterone (Sustanon)FDA Link
01/2013 - 02/2000
3Transcription Factors (Transcription Factor)IBA
01/2012 - 01/2001
3Adrenocorticotropic Hormone (ACTH)FDA Link
02/2011 - 02/2001
3Proteins (Proteins, Gene)FDA Link
10/2007 - 01/2001
3Monoclonal AntibodiesIBA
05/2005 - 01/2001
3ProgesteroneFDA LinkGeneric
01/2004 - 12/2000
3Cadherins (E-Cadherin)IBA
12/2001 - 03/2000
3Keratins (Keratin)IBA
11/2001 - 03/2000
3RetinoidsIBA
06/2001 - 11/2000
3Oxidoreductases (Dehydrogenase)IBA
05/2001 - 01/2000
2LigandsIBA
03/2019 - 01/2012
2RNA (Ribonucleic Acid)IBA
04/2014 - 01/2001
2Biomarkers (Surrogate Marker)IBA
11/2013 - 11/2012
2Capecitabine (Xeloda)FDA Link
11/2013 - 10/2007
2Androgen Receptors (Androgen Receptor)IBA
01/2013 - 09/2001
2Carcinoembryonic AntigenIBA
11/2012 - 03/2000
2ErbB Receptors (EGF Receptor)IBA
11/2012 - 01/2001
2Dexamethasone (Maxidex)FDA LinkGeneric
02/2011 - 07/2001
2ParaffinIBA
10/2010 - 09/2003
2Interleukin-6 (Interleukin 6)IBA
10/2007 - 03/2001
2Pharmaceutical PreparationsIBA
10/2007 - 03/2001
2Gonadal Steroid Hormones (Sex Hormones)IBA
08/2006 - 02/2000
2PPAR gammaIBA
03/2006 - 03/2001
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2005 - 04/2000
2Surface Antigens (Surface Antigen)IBA
06/2004 - 11/2001
2AntibodiesIBA
06/2004 - 04/2000
2alpha Catenin (alpha E-Catenin)IBA
12/2001 - 03/2000
2beta CateninIBA
12/2001 - 01/2001
2Cytochrome P-450 CYP11B2 (CYP11B2)IBA
07/2001 - 02/2000
2Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2001 - 01/2001
2Retinoid X Receptors (Retinoid X Receptor)IBA
06/2001 - 11/2000
2CorticosteroneIBA
03/2001 - 02/2001
2Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2001 - 11/2000
2ProstaglandinsIBA
09/2000 - 08/2000
2Dinoprostone (PGE2)FDA Link
09/2000 - 01/2000
2Hydroxysteroid DehydrogenasesIBA
03/2000 - 01/2000
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
03/2019
1BilirubinIBA
04/2014

Therapy/Procedure

7Therapeutics
03/2019 - 08/2001
5Neoadjuvant Therapy
03/2019 - 10/2005
4Adrenalectomy
02/2011 - 08/2000
1Drug Therapy (Chemotherapy)
03/2019
1Chemoradiotherapy
07/2018